These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [New trends and novel possibilities in functional medical imaging: imaging methods]. Balkay L; Emri M; Krizsán KÁ; Opposits G; Varga J Magy Onkol; 2015 Mar; 59(1):4-9. PubMed ID: 25763907 [TBL] [Abstract][Full Text] [Related]
7. Comparing Strategies in the Design of Responsive Contrast Agents for Magnetic Resonance Imaging: A Case Study with Copper and Zinc. Pierre VC; Harris SM; Pailloux SL Acc Chem Res; 2018 Feb; 51(2):342-351. PubMed ID: 29356506 [TBL] [Abstract][Full Text] [Related]
8. A PARACEST agent responsive to inner- and outer-sphere phosphate ester interactions for MRI applications. Huang CH; Morrow JR J Am Chem Soc; 2009 Apr; 131(12):4206-7. PubMed ID: 19317496 [TBL] [Abstract][Full Text] [Related]
9. PET/MRI: challenges, solutions and perspectives. Herzog H Z Med Phys; 2012 Dec; 22(4):281-98. PubMed ID: 22925652 [TBL] [Abstract][Full Text] [Related]
10. Multimodal liposomes for SPECT/MR imaging as a tool for in situ relaxivity measurements. de Vries A; Kok MB; Sanders HM; Nicolay K; Strijkers GJ; Grüll H Contrast Media Mol Imaging; 2012; 7(1):68-75. PubMed ID: 22344882 [TBL] [Abstract][Full Text] [Related]
11. Design and characterization of a new irreversible responsive PARACEST MRI contrast agent that detects nitric oxide. Liu G; Li Y; Pagel MD Magn Reson Med; 2007 Dec; 58(6):1249-56. PubMed ID: 18046705 [TBL] [Abstract][Full Text] [Related]
12. The cell labeling efficacy, cytotoxicity and relaxivity of copper-activated MRI/PET imaging contrast agents. Patel D; Kell A; Simard B; Xiang B; Lin HY; Tian G Biomaterials; 2011 Feb; 32(4):1167-76. PubMed ID: 21035183 [TBL] [Abstract][Full Text] [Related]
13. Smart Contrast Agents for Magnetic Resonance Imaging. Bonnet CS; Tóth É Chimia (Aarau); 2016; 70(1-2):102-8. PubMed ID: 26931225 [TBL] [Abstract][Full Text] [Related]
15. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action. Caravan P Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207 [TBL] [Abstract][Full Text] [Related]
16. Dual nano-sized contrast agents in PET/MRI: a systematic review. Lahooti A; Sarkar S; Laurent S; Shanehsazzadeh S Contrast Media Mol Imaging; 2016 Nov; 11(6):428-447. PubMed ID: 28102031 [TBL] [Abstract][Full Text] [Related]
17. The hope and hype of multimodality imaging contrast agents. Pagel MD Nanomedicine (Lond); 2011 Aug; 6(6):945-8. PubMed ID: 21955073 [No Abstract] [Full Text] [Related]
18. Neuroimaging techniques in epilepsy. Lai V; Mak HK; Yung AW; Ho WY; Hung KN Hong Kong Med J; 2010 Aug; 16(4):292-8. PubMed ID: 20683073 [TBL] [Abstract][Full Text] [Related]
19. Environment-sensitive and enzyme-sensitive MR contrast agents. Querol M; Bogdanov A Handb Exp Pharmacol; 2008; (185 Pt 2):37-57. PubMed ID: 18626598 [TBL] [Abstract][Full Text] [Related]
20. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents. Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]